Osteosarcoma is a rare and aggressive form of Bone Cancer that primarily affects the long bones, commonly occurring in the arms or legs, and often afflicting adolescents and young adults. Characterized by the proliferation of malignant osteoid tissue, osteosarcoma typically presents with localized pain and swelling. The exact cause is unknown, though genetic factors and preexisting bone conditions may contribute. Diagnosis involves imaging studies such as X-rays, MRI, and biopsy to confirm the presence of malignant cells. Treatment usually involves a combination of surgery to remove the tumor and chemotherapy to target any remaining cancer cells. Limb-salvage procedures may be considered when feasible to preserve limb function.
Despite advances in therapy, osteosarcoma remains challenging to treat due to its aggressive nature and potential for metastasis to other organs. Research continues to explore novel treatment strategies and targeted therapies to improve outcomes for individuals affected by this devastating Bone Cancer. Early detection and prompt intervention are crucial for optimizing the chances of successful treatment and preserving patients' quality of life.
Title : The UK profemur recall and implant cobaltism
Stephen S Tower, University of Alaska Anchorage, United States
Title : The tomographic phenotype and the genotype of wormain bones
Ali Al Kaissi, National Ilizarov Medical Research Center for Traumatology and Orthopaedics, Russian Federation
Title : New treatment of muscle contracture and joint contracture through muscle regeneration with mitochondrial dynamics
Ki Ji Lee, Busan Medical University, Korea, Republic of
Title : New treatment of sarcopenia through muscle regeneration with mitochondrial dynamics
Ki Ji Lee, Busan Medical University, Korea, Republic of
Title : The prevalence and association of self-reported depression symptoms with musculoskeletal pain and quality of life among pregnant women
Youssef Masharawi, Tel Aviv University, Israel
Title : Bipolar hemiarthroplasty under local anesthesia (2%)
Ketan Karabhai Parmar, Aayush Multispecialty Hospital, India